141 institutions hold shares in Trillium Therapeutics Inc. (TRIL), with institutional investors hold 68.87% of the company's shares. The shares outstanding are 100.71M, and...
141 institutions hold shares in Trillium Therapeutics Inc. (TRIL), with institutional investors hold 68.87% of the company's shares. The shares outstanding are 100.71M, and...
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares are 915.53% up in the year-to-date (YTD) period and have moved -4.11% or -$0.43 lower in the latest...